HOME >> MEDICINE >> NEWS
JCI table of contents: May 1, 2007

EDITOR'S PICK

OCT1 required for therapeutic effects of diabetes drug Metformin

The drug metformin is among the most widely prescribed drugs for the treatment of type 2 diabetes and results in an array of therapeutic benefits. Although it has been used for over 30 years, only recently have studies begun to reveal the molecular events responsible for its therapeutic effects. Notably, these studies have shown that metformin acts by phosphorylating the enzyme AMPK, the cellular "energy-sensor", leading to a variety of cellular responses important in diabetic therapy.

A set of mouse and human studies led by Kathleen Giacomini from the University of California, San Francisco and reported in the May 1st issue of the Journal of Clinical Investigation, show that mice lacking organic cation transporter 1 (OCT1) have reduced effects of metformin on AMPK phosphorylation and a decreased ability to control glucose levels. The authors also identified seven mutations in OCT1 in humans that reduce metformin uptake. These studies indicate that OCT1 is important in mediating the therapeutic effects of metformin and that genetic variation in OCT1 in diabetics may contribute to the varied patient responses to this drug.

In an accompanying commentary, Marc Reitman and Eric Schadt from Merck and Rosetta Inpharmatics, respectively, discuss how the identification of individuals that possess specific mutations in certain genes, which are known to affect the action of a particular drug, may eventually help clinicians devise personalized treatment regimes that ensure administration of the right drug for the right person at the right time. They conclude that "tailoring therapeutic choices to the individual should allow lower and better-tolerated doses of drugs that are simultaneously safer and more efficacious. One could eliminate trial-and-error periods of switching among the nine classes of diabetes drugs."

TITLE: Effect of genetic
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
1-May-2007


Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. International symposium on fruit, vegetables headed for Houston
2. Stevens Roundtable: Health, Technology & Society, July 11
3. FDA approves ZYFLO CR extended-release tablets for chronic treatment of asthma
4. Once-fatal metabolic disorders treatable, says Stanford/Packard researcher
5. Clinical review -- A psychological approach to the management of irritable bowel syndrome
6. JCI table of contents -- May 17, 2007
7. JCI table of contents: May 10, 2007
8. New treatments needed for irritable bowel syndrome
9. Americans still not eating enough fruits and vegetables, according to 2 recent studies
10. Slow-release morphine reduces level of intractable cough
11. Less television and more gathering around the dinner table prevents

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... Modere (the “Company”), ... with a presence worldwide, today announced that it built on 2017’s growth momentum, ... grew by double-digits in North America, by more than five times in Europe ...
(Date:1/14/2019)... ... January 14, 2019 , ... The ... availability of VARIZIG® (Varicella Zoster Immune Globulin [Human]) for post-exposure prophylaxis of ... the update, the CDC notes that VARIZIG is commercially available from a broad ...
(Date:1/14/2019)... ... 2019 , ... Dr. Kaveh Kanani D.D.S . is the head of Around the Corner ... general dentist has recently unveiled an inventive method of inserting dental implants. , ... is missing for an extended period of time, the jawbone that used to hold the ...
(Date:1/13/2019)... ... January 12, 2019 , ... On December 13th, The Pennsylvania ... hosted a continuing education (CEU) event entitled, Can You Hear Me Now? Creating ... a series of talks to help develop and cultivate the relationship between mentors ...
(Date:1/11/2019)... ... 11, 2019 , ... In Partnership with the Smiles for Everyone Foundation ... at its Burleson, TX office on February 9. , Dental services provided ... and extractions . For more information, please visit the Monarch Dental website ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... (PRWEB) , ... January 10, 2019 , ... ... wellness company providing nutrition and lifestyle solutions, will crown the U.S. winner of ... Period’s 15 finalists include: Andrea Carrara of Palm Beach, Florida; Barbara Lingle of ...
(Date:1/8/2019)... , ... January 08, 2019 , ... ... been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. ... System and demonstrated a commitment to exemplary care for men suffering from symptoms ...
(Date:1/8/2019)... ... January 08, 2019 , ... Date aired: August 13th, 2018 , Guest: ... excessive evaporation of the tear film, which is naturally 99 percent water, and it ... says water researcher Sharon Kleyne, host of the internationally syndicated radio program, The Sharon ...
Breaking Medicine Technology:
Cached News: